ACCORD and HIPRA Enter into Exclusive Distribution Agreement to Commercialise HIPRA’s COVID-19 vaccine (BIMERVAX®) in the United Kingdom

Posted on by

BIMERVAX®: A booster dose of bivalent recombinant protein vaccine provides immunisation in people over 16 years of age LONDON and GIRONA, Spain, Aug. 4, 2023 /PRNewswire/ — Accord Healthcare, Ltd. (Accord) and HIPRA, today announced that they have entered into an exclusive distribution…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.